80
SCORE
Bifidobacterium infantis EVC001
Probiotic strain · Pediatric · Breastfed infant
Tier 1 — Strong Evidence
What it is
The strain (Evivo) restores the dominant bifidobacterium of breastfed infant gut, which has largely disappeared from Western infants since formula feeding became prevalent. RCT data show colonisation persistence and reduction in markers of inflammation. AAP-friendly; no major safety signals in healthy term infants.
Efficacy
4/5
Safety
5/5
Research
4/5
Onset
3/5
Cost
2/5
Drug-int.
5/5
Dose
8 billion CFU/day mixed with breastmilk for first 100 days
Time of day & tips
Specific to breastfed infants; not interchangeable with adult probiotics; pediatrician should be informed.
Sensitive populations: This supplement's evidence base touches pregnancy, pediatric, or other sensitive populations. Confirm any change with your healthcare provider before use.
Compare or learn more
Compare with another supplement →
Browse by symptom →
Open the full interactive view →